Management ChangeJul 6, 2026, 06:08 AM
Coda Octopus Appoints Mark Kelly as New CFO
AI Summary
Coda Octopus Group, Inc. announced that Interim Chief Financial Officer Gayle Jardine will retire from her position effective August 3, 2026. The company has appointed Mark Kelly as the new Chief Financial Officer, with his appointment also effective August 3, 2026. Mr. Kelly brings extensive financial experience from previous roles at Medac Pharma, Chubb Insurance, Twist Bioscience Corp., and Charles River Laboratories. His compensation includes an annual base salary of £165,000 (approximately $218,625) and a $40,000 restricted stock grant.
Key Highlights
- Gayle Jardine to retire as Interim CFO of Coda Octopus Group, Inc. effective August 3, 2026.
- Mark Kelly appointed Chief Financial Officer, effective August 3, 2026.
- Mr. Kelly was Finance Director at Medac Pharma from 2024 to 2025.
- He served as Head of Glasgow Finance at Chubb Insurance from 2022 to 2024.
- Mr. Kelly was Finance Director at Twist Bioscience Corp. from 2021 to 2022.
- He was Senior Finance Director at Charles River Laboratories from 2016 to 2021.
- Mr. Kelly's annual base salary is £165,000 (approximately $218,625).
- He will receive a $40,000 restricted stock grant, vesting in two equal annual installments.
Price Impact
More from CODA